Are you over 18 and want to see adult content?
More Annotations
A complete backup of notiziemusica.it/chi-e-la-regina-del-rock/curiosita/
Are you over 18 and want to see adult content?
A complete backup of www.libertatea.ro/entertainment/autoironia-ma-protejeaza-de-judecati-rautacioase-maia-morgenstern-a-povesti
Are you over 18 and want to see adult content?
A complete backup of www.jagran.com/lifestyle/miscellaneous-happy-valentine-day-2020-wishes-images-whatsapp-stickers-gif-photos-
Are you over 18 and want to see adult content?
Favourite Annotations
Material Educativo | Material Educativo para la educacion basica
Are you over 18 and want to see adult content?
Optometrist, Eye Doctor in Jacksonville FL | Advanced Eye Care and Optical
Are you over 18 and want to see adult content?
Loja Mundomax - Instrumentos Musicais e Eletrônicos
Are you over 18 and want to see adult content?
Risk - Reinsurance - Retirement - Health - Data & Analytics | Aon
Are you over 18 and want to see adult content?
logsticacomercial2016
Are you over 18 and want to see adult content?
Spletno gostovanje in gostovanje strani | Domovanje.com
Are you over 18 and want to see adult content?
Garaże blaszane tynkowane od producenta - zadzwoń i sprawdź naszą jakość i ceny! - Twojgaraz.com
Are you over 18 and want to see adult content?
skwachays.com – Skwachàys Lodge – Unique Aboriginal Experience
Are you over 18 and want to see adult content?
Text
SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profit VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profit VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
COMPANY - YPSOMED - GROUP The Ypsomed Group. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injections REPORTS - YPSOMED - GROUP Download reports and fact sheets. On this page you can download all financial publications of Ypsomed Holding AG covering the last five years of business activity. If you prefer a printed copy, please use the order form on this page. 2020/21. Semiannual Report 2020/21 (616.4 KiB) Investor Fact Sheet - Based on semiannual report 2020/21 (230.7KiB)
JOBS & CAREERS
Just a few clicks to the next step in your career. Ypsomed has a variety of different professions available for you: Ypsomed offers an interesting work environment for apprentices, students, job beginners as well as experienced professionals, ranging from development and production, through to marketing and quality assurance.PRESS RELEASES
11/03/2020 - 7:00am Press Releases Ypsomed Group. Burgdorf – Ypsomed (SWX: YPSN) increased sales by 4.6% or CHF 8.7 million in the first six months of 2020/21 compared to the previous year, and generated an operating profit (EBIT) of CHF 8.3 million. The company continued on its growth course in a challenging environment, driving forward all DIVIDEND - YPSOMED - GROUP The next Annual General Meeting of Ypsomed Holding AG will be held in Burgdorf on 1st Juli 2020. 2014/15. 2015/16. 2016/17. 2017/18. 2019/19. Dividend per share in CHF. 0.60. 1.00.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector.DIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
ANNUAL GENERAL MEETING Annual General Meeting. With the third Swiss corporate tax reform that came into force at the beginning of 2020, only a maximum of half of the dividend can be distributed tax-exempt from reserves from capital contributions. Ypsomed adjusts the dividend structure accordingly. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profitDIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple andPEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients.SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profitDIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple andPEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients.SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
COMPANY - YPSOMED - GROUP The Ypsomed Group. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injectionsJOBS & CAREERS
Ypsomed has a variety of different professions available for you: Ypsomed offers an interesting work environment for apprentices, students, job beginners as well as experienced professionals, ranging from development and production, through to marketing and quality assurance. Take the next step in your professional career.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. ANNUAL GENERAL MEETING Annual General Meeting. With the third Swiss corporate tax reform that came into force at the beginning of 2020, only a maximum of half of the dividend can be distributed tax-exempt from reserves from capital contributions. Ypsomed adjusts the dividend structure accordingly. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
FIRST MARKET ENTRY OF YPSOMATE AUTOINJECTOR FROM YPSOMED The pre-filled autoinjector is based on Ypsomed's YpsoMate platform and is designed for subcutaneous injection of liquid drugs. Terumo assembles the YpsoMate with its proprietary PLAJEX ™ syringe for administration of the drug Hulio ® with the active ingredient adalimumab. Hulio ® received market approval in the European Union in September 2018.. The first commercial deliveries of theSELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profitDIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients.SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profitDIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients.SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
COMPANY - YPSOMED - GROUP The Ypsomed Group. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injectionsJOBS & CAREERS
Ypsomed has a variety of different professions available for you: Ypsomed offers an interesting work environment for apprentices, students, job beginners as well as experienced professionals, ranging from development and production, through to marketing and quality assurance. Take the next step in your professional career.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. LILLY AND YPSOMED COLLABORATE TO ADVANCE AN AUTOMATED Burgdorf / Indianapolis – Eli Lilly and Company (NYSE: LLY) and Ypsomed (SWX: YPSN) announced today a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly’s connected diabetes solutions. Under the terms of the agreement, Lilly will commercialize the system, which is currently LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Enklare och lättare egenvård. Ypsomed-gruppen är en ledande utvecklare och tillverkare av system för injektion och infusion för egenvård, och en erkänd diabetesspecialist med över 30 års erfarenhet.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profitDIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring a high level of patient comfort.SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profitDIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring a high level of patient comfort.SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
COMPANY - YPSOMED - GROUP The Ypsomed Group. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injectionsJOBS & CAREERS
Just a few clicks to the next step in your career. Ypsomed has a variety of different professions available for you: Ypsomed offers an interesting work environment for apprentices, students, job beginners as well as experienced professionals, ranging from development and production, through to marketing and quality assurance.DIABETES CARE
The intelligent and discreet mylife Unio Neva is the latest mylife blood glucose monitoring system. Features provided by intuitive control of the meter include the adjustment of reminder functions and the setting of four event markers per measurement, which can be editedlater on.
PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector.AUTOINJECTORS
UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. VarioJect The variable single dose injector. LyoTwist Dual-chamber monodose device. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients. LILLY AND YPSOMED COLLABORATE TO ADVANCE AN AUTOMATED Burgdorf / Indianapolis – Eli Lilly and Company (NYSE: LLY) and Ypsomed (SWX: YPSN) announced today a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly’s connected diabetes solutions. Under the terms of the agreement, Lilly will commercialize the system, which is currently LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profit REPORTS - YPSOMED - GROUP Download reports and fact sheets. On this page you can download all financial publications of Ypsomed Holding AG covering the last five years of business activity. If you prefer a printed copy, please use the order form on this page. 2020/21. Semiannual Report 2020/21 (616.4 KiB) Investor Fact Sheet - Based on semiannual report 2020/21 (230.7KiB)
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients. LILLY AND YPSOMED COLLABORATE TO ADVANCE AN AUTOMATED Burgdorf / Indianapolis – Eli Lilly and Company (NYSE: LLY) and Ypsomed (SWX: YPSN) announced today a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly’s connected diabetes solutions. Under the terms of the agreement, Lilly will commercialize the system, which is currentlySELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profit REPORTS - YPSOMED - GROUP Download reports and fact sheets. On this page you can download all financial publications of Ypsomed Holding AG covering the last five years of business activity. If you prefer a printed copy, please use the order form on this page. 2020/21. Semiannual Report 2020/21 (616.4 KiB) Investor Fact Sheet - Based on semiannual report 2020/21 (230.7KiB)
VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible. YPSOMATE – THE 2-STEP AUTOINJECTOR YpsoMate – the 2-step autoinjector. The YpsoMate autoinjector is an automated disposable injection device for 1 ml long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients. Push-on-skin release for most simple and SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients. LILLY AND YPSOMED COLLABORATE TO ADVANCE AN AUTOMATED Burgdorf / Indianapolis – Eli Lilly and Company (NYSE: LLY) and Ypsomed (SWX: YPSN) announced today a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly’s connected diabetes solutions. Under the terms of the agreement, Lilly will commercialize the system, which is currentlySELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector.AUTOINJECTORS
UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. VarioJect The variable single dose injector. LyoTwist Dual-chamber monodose device. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring a high level of patient comfort. LILLY AND YPSOMED COLLABORATE TO ADVANCE AN AUTOMATED Burgdorf / Indianapolis – Eli Lilly and Company (NYSE: LLY) and Ypsomed (SWX: YPSN) announced today a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly’s connected diabetes solutions. Under the terms of the agreement, Lilly will commercialize the system, which is currentlyWEARABLE INJECTORS
These larger injection volumes require a new product concept, a large-volume wearable injector. Compared to an infusion pump, which performs drug infusions over hours or days, the large-volume patch injector is intended to administer 2 – 10 ml of drug, frequently of higher viscosity, within 2 – 15 minutes. The low injection frequencyand
LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
FIRST MARKET ENTRY OF YPSOMATE AUTOINJECTOR FROM YPSOMED The pre-filled autoinjector is based on Ypsomed's YpsoMate platform and is designed for subcutaneous injection of liquid drugs. Terumo assembles the YpsoMate with its proprietary PLAJEX ™ syringe for administration of the drug Hulio ® with the active ingredient adalimumab. Hulio ® received market approval in the European Union in September 2018.. The first commercial deliveries of theSELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profit VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring a high level of patient comfort. LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profit VARIOJECT – THE VARIABLE SINGLE DOSE INJECTOR VarioJect – the variable single dose injector. The VarioJect is a simple single use variable dose injector for pre-filled syringes or cartridges. It guides the patient through priming followed by dialing the dose to then inject the set dose volume. After use the device is locked and no further dosing is possible.PEN INJECTORS
Pen injectors. ServoPen The automatic reusable pen. YpsoPen The intuitive reusable pen. UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. SMARTPILOT – GO FOR SMART GUIDANCE The SmartPilot add-on transforms the 2-step autoinjector YpsoMate into a connected product system. SmartPilot for YpsoMate enables advanced adherence monitoring by transforming the proven YpsoMate autoinjector into a fully connected smart product system. It supports the seamless provision of therapy-relevant data to patients, physicians, and other healthcare stakeholders. YPSOMATE – THE 2-STEP LARGE VOLUME AUTOINJECTOR YpsoMate 2.25 – the 2-step large volume autoinjector. YpsoMate 2.25 and YpsoMate 2.25 Pro autoinjectors are automated disposable injection devices for 2.25 ml pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic, and preferred by patients. UNOPEN – THE INTUITIVE DISPOSABLE PEN The UnoPen is an intuitive variable dose pen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring a high level of patient comfort. LYOTWIST – DUAL-CHAMBER MONODOSE DEVICE The LyoTwist monodose device family for dual-chamber cartridges is based on Ypsomed’s proven twisting method for reconstitution and priming. The devices provide excellent visualisation of the reconstitution, priming and injection steps. A complete range of device versions ensure that various drug, therapy and patient needsare met.
SELFCARE SOLUTIONS
Delivery Systems. Ypsomed Delivery Systems (YDS) bietet ein umfassendes Spektrum an Technologien und Dienstleistungen für zuverlässige und benutzerfreundliche Injektionssysteme zur Selbstmedikation. Unsere Kunden sind Pharma- und Biotechnologieunternehmen, die Medikamente zur Injektion entwickeln, herstellen und vertreiben.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. PRODUCTS - YPSOMED - CANADA Ypsomed Delivery Systems (YDS) is the umbrella brand for injection systems and services in the B2B market. Ypsomed offers pharmaceutical customers over 30 years of development experience, tried-and-tested modular platform technologies, flexible manufacturing concepts and country-specific final packaging and logistics. Explore YpsomedDelivery
MEDIA & INVESTORS
Key financials. In the financial year 2020/21, we achieved consolidated sales of CHF 403.7 million (previous year: CHF 394.3 million). In a difficult environment, we have thus achieved a growth of CHF 9.4 million or 2.4% in the reporting period. The operating result (EBIT) amounted to CHF 9.3 million (previous year: CHF 9.7 million). Net profit REPORTS - YPSOMED - GROUP Download reports and fact sheets. On this page you can download all financial publications of Ypsomed Holding AG covering the last five years of business activity. If you prefer a printed copy, please use the order form on this page. 2020/21. Semiannual Report 2020/21 (616.4 KiB) Investor Fact Sheet - Based on semiannual report 2020/21 (230.7KiB)
DIABETES CARE
Diabetes Care. mylife Diabetescare is the name of Ypsomed’s range of products and services for people with diabetes. It provides them with everything they need for reliable and simple self-treatment, giving them more freedom and flexibility in their lives. mylife Loop Program - Teaser Video. Play/Pause.AUTOINJECTORS
UnoPen The intuitive disposable pen. FixPen The easy-to-use fixed dose pen. Autoinjectors. YpsoMate The 2-step autoinjector. YpsoMate Zero The zero carbon emission 2-step autoinjector. YpsoMate 2.25 The 2-step large volume autoinjector. VarioJect The variable single dose injector. LyoTwist Dual-chamber monodose device. YPSOPEN – THE INTUITIVE REUSABLE PEN YpsoPen – the intuitive dial & dose reusable pen. The YpsoPen is an intuitive variable dose insulin pen providing a familiar handling experience and high level of patient acceptance. Intuitive and proven dial and dose handling concept for maximum patient acceptance. Easy dose setting and correction ensuring high patient comfort.WEARABLE INJECTORS
These larger injection volumes require a new product concept, a large-volume wearable injector. Compared to an infusion pump, which performs drug infusions over hours or days, the large-volume patch injector is intended to administer 2 – 10 ml of drug, frequently of higher viscosity, within 2 – 15 minutes. The low injection frequencyand
ALLIANCE TO ZERO FOUNDED TO ACHIEVE NET ZERO EMISSIONS Burgdorf – Today, eight companies representing the pharmaceutical supply chain for pharma products announced the founding of the Alliance to Zero, a non-profit membership association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net zero emissions in line with the goals of the Paris Climate Agreement.SELFCARE SOLUTIONS
Welcome to Ypsomed Selfcare Solutions. Making selfcare simpler and easier. The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience.Keywords __
Menu
* Open submenu ( Company ) Company* Delivery Systems
* Diabetes Care
* Open submenu ( Jobs & Careers ) Jobs & Careers * Open submenu ( Media & Investors ) Media & Investors * __Open submenu (Switzerland (Group))Switzerland (Group)* ENGLISHDeutsch
Close submenu ( Company ) Company* Vision - Mission
* Open submenu ( Corporate Strategy ) Corporate Strategy* Group structure
* Management team
* Open submenu ( Responsibility & Engagement ) Responsibility &Engagement
* Lean Management
* YpsoStories
* History
* Suppliers
* Open submenu ( Contact ) Contact Close submenu ( Corporate Strategy ) Corporate Strategy * Our corporate responsibility Close submenu ( Responsibility & Engagement ) Responsibility &Engagement
* Environment
* Open submenu ( Employees ) Employees* Integrity
* Disclosure of grants* Risk management
Close submenu ( Employees ) Employees * Human Resources Policy Close submenu ( Contact ) Contact * Subsidiaries and Distributors Close submenu ( Jobs & Careers ) Jobs & Careers * Open submenu ( Vacant Positions ) Vacant Positions * Open submenu ( Working for Ypsomed ) Working for Ypsomed * Open submenu ( Apprenticeship ) Apprenticeship* Recruiting Events
Close submenu ( Vacant Positions ) Vacant Positions* Professionals
* Job beginners
* Apprenticeships
* For recruitment agencies Close submenu ( Working for Ypsomed ) Working for Ypsomed * Career and continuing professional development * Programmes for employee development* Quality of life
* Working conditions and benefits Close submenu ( Apprenticeship ) Apprenticeship * Training conditions at Ypsomed Close submenu ( Media & Investors ) Media & Investors* Facts & Figures
* Open submenu ( Press releases ) Press releases * Financial calendar * Annual General Meeting * Open submenu ( Reports ) Reports* Presentations
* Open submenu ( Shares ) Shares * Open submenu ( Corporate Governance ) Corporate Governance Close submenu ( Press releases ) Press releases* News Service
* Image gallery
Close submenu ( Reports ) Reports * Order printed reports Close submenu ( Shares ) Shares * Financial analysts coverage* Share key data
* Dividend
Close submenu ( Corporate Governance ) Corporate Governance* Code of Conduct
Close submenu (Switzerland (Group))Switzerland (Group) * SWITZERLAND (GROUP)* Australia
* Austria
* Belgium
* Canada
* China
* Czech Republic
* Denmark
* Finland
* France
* Germany
* Italy
* Niederlands
* Norway
* Poland
* Spain
* Sweden
* United Kingdom
Skip navigation
* ENGLISH
* Deutsch
__Switzerland (Group) __Ypsomed Websites * SWITZERLAND (GROUP)* Australia
* Austria
* Belgium
* Canada
* China
* Czech Republic
* Denmark
* Finland
* France
* Germany
* Italy
* Niederlands
* Norway
* Poland
* Spain
* Sweden
* United Kingdom
Keywords __
Skip navigation
* Company
* Vision - Mission
* Corporate Strategy * Our corporate responsibility* Group structure
* Management team
* Responsibility & Engagement* Environment
* Employees
* Human Resources Policy* Integrity
* Disclosure of grants* Risk management
* Lean Management
* YpsoStories
* History
* Suppliers
* Contact
* Subsidiaries and Distributors* Delivery Systems
* Diabetes Care
* Jobs & Careers
* Vacant Positions
* Professionals
* Job beginners
* Apprenticeships
* For recruitment agencies * Working for Ypsomed * Career and continuing professional development * Programmes for employee development* Quality of life
* Working conditions and benefits* Apprenticeship
* Training conditions at Ypsomed* Recruiting Events
* Media & Investors
* Facts & Figures
* Press releases
* News Service
* Image gallery
* Financial calendar * Annual General Meeting* Reports
* Order printed reports* Presentations
* Shares
* Financial analysts coverage* Share key data
* Dividend
* Corporate Governance* Code of Conduct
MAKING SELFCARE SIMPLER AND EASIER The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. INJECTION SYSTEMS FOR SELF-MEDICATION__
DELIVERY SYSTEMS
Ypsomed Delivery Systems (YDS) provides a complete range of technologies and services for reliable and user-friendly injection systems for self-medication. Our customers are pharmaceutical and biotechnology companies that develop, manufacture and market injectable therapies.We offer:
__Modular and proven platform technologies __Comprehensive services tailored to our customers requirements __A full range of in-house manufacturing capabilities Explore YpsomedDelivery Systems
SOLUTIONS FOR PEOPLE WITH DIABETES MELLITUS__
DIABETESCARE
With its mylife Diabetescare brand, Ypsomed offers a comprehensive portfolio of products and services for people with diabetes. This allows users easy, discreet and reliable self-treatment. With mylife Diabetescare, self-treatment becomes simpler and easier.We offer:
__Infusion Systems
__Blood glucose monitoring systems __Therapy management __Pen needles Explore Ypsomed Diabetes Care__
LATEST NEWS PRESS RELEASES02.06.2021
Alliance to Zero founded to achieve net zero emissions across the pharmaceutical supply chain Read more … Alliance to Zero founded to achieve net zero emissions across the pharmaceutical supply chain26.05.2021
Ypsomed continues to invest in growth Read more … Ypsomed continues to invest in growth04.01.2021
Ypsomed reaches agreement in legal dispute with Insulet Read more … Ypsomed reaches agreement in legal dispute with Insulet19.11.2020
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes Read more … Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetesMore news
__
ENJOY SIMPLICITY MYLIFE YPSOPUMP Discover the simplicity of our new insulin pump mylife YpsoPump. The easy-to-learn insulin pump system, which features the essentialfunctions.
Explore mylife YpsoPump__
PRODUCTS BUILT ON PLATFORMS Our modular and proven platform technologies guarantee that Ypsomed injection systems are rapidly available for clinical studies and market introduction. Explore our platform productsYPSOSTORIES
Would you like to get to know us better? Read our exciting stories and find out more about the world of Ypsomed.Read YpsoStories
JOBS AND CAREERS
Time for a new challenge? Our jobs offer interesting opportunities for your development and career.Vacant positions
NEWSLETTER
Are you interested in receiving the latest industry, product and development news from Ypsomed Delivery Systems? Just subscribe to ournewsletter.
Subscribe
TOP
Skip navigation
* Imprint
* Terms of service
* Data privacy
* Cookie Policy
* Quality certificatesSkip navigation
* Suppliers
* Opening hours for goods delivery * Subsidiaries and distributors* Contact us
* Sitemap
CONTACT
Ypsomed AG
Headquarters BurgdorfBrunnmattstrasse 6
3401 Burgdorf
Switzerland
T +41 (0)34 424 41 11 F +41 (0)34 424 41 22info@ypsomed.com
Follow us on
__
__
__
__
__
__
Page last update: 06/02/2021 - 10:03am © byFILTERS
Information storage and accessCancel Apply
PRIVACY PREFERENCE CENTER When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.*
STRICTLY NECESSARY COOKIESAlways Active
Strictly Necessary Cookies These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.*
FUNCTIONAL COOKIES
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not functionproperly.
*
PERFORMANCE COOKIES
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.*
TARGETING COOKIES
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Allow All Confirm My ChoicesBack Button
Back
Vendor Search Search IconVENDORS LIST
Filter Icon Filters (0) Consent Leg.InterestSelect All
Select All Vendors
Select All Vendors
Select All Hosts
This website uses cookies as long as you allow this in the settings of your web browser. Cookies tell us which parts of our website you have visited and help us to measure the effectiveness of advertisements and web searches. They also give us insights into user behaviour so that we can improve our communications and our products. Please read our Privacy Policy to find out which cookies we use and how you can block them.Data protection declaration Cookies Settings Accept All CookiesDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0